

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 9.55361170 |
| 2 | eosinophil migration (GO:0072677) | 9.51177891 |
| 3 | regulation of sister chromatid cohesion (GO:0007063) | 9.49875021 |
| 4 | regulation of mononuclear cell migration (GO:0071675) | 9.35668825 |
| 5 | branch elongation of an epithelium (GO:0060602) | 8.57836813 |
| 6 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 8.16430460 |
| 7 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 7.87235925 |
| 8 | positive regulation of chromosome segregation (GO:0051984) | 7.86474465 |
| 9 | fucose catabolic process (GO:0019317) | 7.78282957 |
| 10 | L-fucose metabolic process (GO:0042354) | 7.78282957 |
| 11 | L-fucose catabolic process (GO:0042355) | 7.78282957 |
| 12 | vesicle fusion (GO:0006906) | 7.66632225 |
| 13 | peptidyl-lysine dimethylation (GO:0018027) | 7.64461198 |
| 14 | coenzyme A biosynthetic process (GO:0015937) | 7.22052869 |
| 15 | ribosomal small subunit assembly (GO:0000028) | 7.11930430 |
| 16 | autophagic vacuole fusion (GO:0000046) | 7.01455863 |
| 17 | localization within membrane (GO:0051668) | 6.71098606 |
| 18 | macrophage chemotaxis (GO:0048246) | 6.51856828 |
| 19 | organ growth (GO:0035265) | 6.50611872 |
| 20 | axis elongation (GO:0003401) | 6.47148191 |
| 21 | regulation of beta-amyloid formation (GO:1902003) | 5.94555114 |
| 22 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 5.92854889 |
| 23 | establishment of mitotic spindle orientation (GO:0000132) | 5.86717645 |
| 24 | negative regulation of GTPase activity (GO:0034260) | 5.85460699 |
| 25 | negative regulation of GTP catabolic process (GO:0033125) | 5.85460699 |
| 26 | positive regulation of calcium ion import (GO:0090280) | 5.81616408 |
| 27 | regulation of T cell receptor signaling pathway (GO:0050856) | 5.56863389 |
| 28 | organelle membrane fusion (GO:0090174) | 5.54436016 |
| 29 | monocyte chemotaxis (GO:0002548) | 5.44248447 |
| 30 | protein import into peroxisome matrix (GO:0016558) | 5.41172961 |
| 31 | acrosome assembly (GO:0001675) | 5.15826938 |
| 32 | establishment of mitotic spindle localization (GO:0040001) | 5.14760707 |
| 33 | histone H3-K9 methylation (GO:0051567) | 5.14638144 |
| 34 | establishment of spindle orientation (GO:0051294) | 5.11923601 |
| 35 | double-strand break repair via nonhomologous end joining (GO:0006303) | 5.04109360 |
| 36 | non-recombinational repair (GO:0000726) | 5.04109360 |
| 37 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 4.98427896 |
| 38 | seminiferous tubule development (GO:0072520) | 4.89689706 |
| 39 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 4.78296808 |
| 40 | negative regulation of circadian rhythm (GO:0042754) | 4.76767559 |
| 41 | positive chemotaxis (GO:0050918) | 4.72250309 |
| 42 | oxidative demethylation (GO:0070989) | 4.67247691 |
| 43 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 4.67206427 |
| 44 | organelle fusion (GO:0048284) | 4.65473686 |
| 45 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.63832543 |
| 46 | regulation of stem cell maintenance (GO:2000036) | 4.60336100 |
| 47 | pantothenate metabolic process (GO:0015939) | 4.55380397 |
| 48 | purine nucleoside bisphosphate biosynthetic process (GO:0034033) | 4.54423764 |
| 49 | ribonucleoside bisphosphate biosynthetic process (GO:0034030) | 4.54423764 |
| 50 | nucleoside bisphosphate biosynthetic process (GO:0033866) | 4.54423764 |
| 51 | fucose metabolic process (GO:0006004) | 4.46401328 |
| 52 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 4.41709866 |
| 53 | protein targeting to vacuole (GO:0006623) | 4.38605840 |
| 54 | protein targeting to lysosome (GO:0006622) | 4.38605840 |
| 55 | establishment of protein localization to vacuole (GO:0072666) | 4.38605840 |
| 56 | histone H3-K9 modification (GO:0061647) | 4.27961137 |
| 57 | regulation of autophagic vacuole assembly (GO:2000785) | 4.22576133 |
| 58 | regulation of fibroblast growth factor receptor signaling pathway (GO:0040036) | 4.22246126 |
| 59 | coenzyme A metabolic process (GO:0015936) | 4.17054493 |
| 60 | fucosylation (GO:0036065) | 4.15322789 |
| 61 | membrane budding (GO:0006900) | 4.12603077 |
| 62 | negative regulation of purine nucleotide catabolic process (GO:0033122) | 4.06871964 |
| 63 | single-organism membrane fusion (GO:0044801) | 4.03602221 |
| 64 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 3.99153058 |
| 65 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.91210866 |
| 66 | negative regulation of nucleotide catabolic process (GO:0030812) | 3.89608187 |
| 67 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.80133561 |
| 68 | regulation of cellular amide metabolic process (GO:0034248) | 3.79992028 |
| 69 | regulation of peptidyl-threonine phosphorylation (GO:0010799) | 3.78313749 |
| 70 | negative regulation of nucleoside metabolic process (GO:0045978) | 3.77404389 |
| 71 | establishment of spindle localization (GO:0051293) | 3.73060774 |
| 72 | vesicle targeting (GO:0006903) | 3.69367786 |
| 73 | ER to Golgi vesicle-mediated transport (GO:0006888) | 3.61670425 |
| 74 | regulation of vacuole organization (GO:0044088) | 3.53918811 |
| 75 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2 | 3.53513718 |
| 76 | imidazole-containing compound metabolic process (GO:0052803) | 3.53388644 |
| 77 | regulation of calcium ion import (GO:0090279) | 3.53070795 |
| 78 | protein localization to peroxisome (GO:0072662) | 3.50643257 |
| 79 | protein targeting to peroxisome (GO:0006625) | 3.50643257 |
| 80 | establishment of protein localization to peroxisome (GO:0072663) | 3.50643257 |
| 81 | sodium-independent organic anion transport (GO:0043252) | 3.46341724 |
| 82 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.44260347 |
| 83 | DNA integration (GO:0015074) | 3.43021591 |
| 84 | COPI coating of Golgi vesicle (GO:0048205) | 3.38349816 |
| 85 | Golgi transport vesicle coating (GO:0048200) | 3.38349816 |
| 86 | peptidyl-lysine trimethylation (GO:0018023) | 3.31818150 |
| 87 | cellular senescence (GO:0090398) | 3.27543754 |
| 88 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.26794839 |
| 89 | COPII vesicle coating (GO:0048208) | 3.26726477 |
| 90 | labyrinthine layer development (GO:0060711) | 3.26331177 |
| 91 | negative regulation of macroautophagy (GO:0016242) | 3.26261215 |
| 92 | peroxisomal transport (GO:0043574) | 3.26087150 |
| 93 | protein prenylation (GO:0018342) | 12.6792824 |
| 94 | prenylation (GO:0097354) | 12.6792824 |
| 95 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 12.1612368 |
| 96 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 12.1612368 |
| 97 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 12.1612368 |
| 98 | negative regulation of Ras GTPase activity (GO:0034261) | 12.1529586 |
| 99 | eosinophil chemotaxis (GO:0048245) | 10.5200213 |
| 100 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 10.1844971 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 8.65098072 |
| 2 | VDR_22108803_ChIP-Seq_LS180_Human | 6.20213776 |
| 3 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.69090637 |
| 4 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 4.32320817 |
| 5 | AR_21572438_ChIP-Seq_LNCaP_Human | 3.51300080 |
| 6 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.01140271 |
| 7 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.65749541 |
| 8 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 2.52036591 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.46376465 |
| 10 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.37642341 |
| 11 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.26391557 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.11058042 |
| 13 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.08919971 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 11.8008510 |
| 15 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.91375798 |
| 16 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.91375798 |
| 17 | RXR_22108803_ChIP-Seq_LS180_Human | 1.86389782 |
| 18 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.64814662 |
| 19 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.63590814 |
| 20 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.63536564 |
| 21 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.60106963 |
| 22 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.60106963 |
| 23 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.60106963 |
| 24 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.57624772 |
| 25 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.57164367 |
| 26 | TP53_16413492_ChIP-PET_HCT116_Human | 1.45419302 |
| 27 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.43447741 |
| 28 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.43349998 |
| 29 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.41286753 |
| 30 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.37948234 |
| 31 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.31286598 |
| 32 | GATA3_26560356_Chip-Seq_TH1_Human | 1.30180196 |
| 33 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.25792621 |
| 34 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.16648069 |
| 35 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.15846373 |
| 36 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.15255236 |
| 37 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.11360792 |
| 38 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08622456 |
| 39 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.07152108 |
| 40 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.04781881 |
| 41 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03043235 |
| 42 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02050355 |
| 43 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.01659609 |
| 44 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97868809 |
| 45 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.96343982 |
| 46 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.95063325 |
| 47 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.93820956 |
| 48 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.93410114 |
| 49 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.92669065 |
| 50 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.90266336 |
| 51 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.89942554 |
| 52 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.89610633 |
| 53 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.89592256 |
| 54 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.89236374 |
| 55 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.87720770 |
| 56 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.85014522 |
| 57 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.83807987 |
| 58 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.80500288 |
| 59 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.79763504 |
| 60 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.79345582 |
| 61 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.77467875 |
| 62 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.76380494 |
| 63 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.74316885 |
| 64 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73510285 |
| 65 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.71110380 |
| 66 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.67820244 |
| 67 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.67378540 |
| 68 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.66447448 |
| 69 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.66174498 |
| 70 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.66174498 |
| 71 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.65515116 |
| 72 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.65047350 |
| 73 | GATA2_19941826_ChIP-Seq_K562_Human | 0.64873859 |
| 74 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.64824512 |
| 75 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.64655168 |
| 76 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.64307682 |
| 77 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.63940690 |
| 78 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.63798263 |
| 79 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.62094896 |
| 80 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.61211905 |
| 81 | FUS_26573619_Chip-Seq_HEK293_Human | 0.60398895 |
| 82 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.59634721 |
| 83 | P300_19829295_ChIP-Seq_ESCs_Human | 0.59538226 |
| 84 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.58927836 |
| 85 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.57984419 |
| 86 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.57191511 |
| 87 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.56707123 |
| 88 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 0.56348919 |
| 89 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.54637919 |
| 90 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.54565243 |
| 91 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.54492231 |
| 92 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.54255725 |
| 93 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.53562249 |
| 94 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.53553365 |
| 95 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.53273433 |
| 96 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.52734007 |
| 97 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.51485624 |
| 98 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.51198891 |
| 99 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.51164717 |
| 100 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.50876032 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 9.98784569 |
| 2 | MP0006082_CNS_inflammation | 5.30547393 |
| 3 | MP0001664_abnormal_digestion | 3.38537532 |
| 4 | MP0000467_abnormal_esophagus_morphology | 3.34282778 |
| 5 | MP0001663_abnormal_digestive_system | 3.22438590 |
| 6 | MP0003115_abnormal_respiratory_system | 2.63140852 |
| 7 | MP0001919_abnormal_reproductive_system | 2.60708839 |
| 8 | MP0000383_abnormal_hair_follicle | 2.52234964 |
| 9 | MP0005381_digestive/alimentary_phenotyp | 2.49885667 |
| 10 | MP0002751_abnormal_autonomic_nervous | 2.43596153 |
| 11 | MP0000566_synostosis | 12.9228272 |
| 12 | MP0001915_intracranial_hemorrhage | 1.81153681 |
| 13 | MP0001545_abnormal_hematopoietic_system | 1.75204160 |
| 14 | MP0005397_hematopoietic_system_phenotyp | 1.75204160 |
| 15 | MP0000534_abnormal_ureter_morphology | 1.74679317 |
| 16 | MP0002876_abnormal_thyroid_physiology | 1.73111037 |
| 17 | MP0005166_decreased_susceptibility_to | 1.71829975 |
| 18 | MP0010678_abnormal_skin_adnexa | 1.66638090 |
| 19 | MP0005389_reproductive_system_phenotype | 1.63924031 |
| 20 | MP0003937_abnormal_limbs/digits/tail_de | 1.59041564 |
| 21 | MP0003453_abnormal_keratinocyte_physiol | 1.50978648 |
| 22 | MP0000428_abnormal_craniofacial_morphol | 1.48938862 |
| 23 | MP0005076_abnormal_cell_differentiation | 1.42458778 |
| 24 | MP0000858_altered_metastatic_potential | 1.15739781 |
| 25 | MP0005501_abnormal_skin_physiology | 1.14547522 |
| 26 | MP0001286_abnormal_eye_development | 1.05281449 |
| 27 | MP0001293_anophthalmia | 1.02838973 |
| 28 | MP0000490_abnormal_crypts_of | 0.99097420 |
| 29 | MP0003763_abnormal_thymus_physiology | 0.97730783 |
| 30 | MP0003942_abnormal_urinary_system | 0.97054095 |
| 31 | MP0002109_abnormal_limb_morphology | 0.91023705 |
| 32 | MP0008004_abnormal_stomach_pH | 0.90496722 |
| 33 | MP0002115_abnormal_skeleton_extremities | 0.90097302 |
| 34 | MP0003329_amyloid_beta_deposits | 0.89380890 |
| 35 | MP0002019_abnormal_tumor_incidence | 0.88777792 |
| 36 | MP0000470_abnormal_stomach_morphology | 0.88411728 |
| 37 | MP0005508_abnormal_skeleton_morphology | 0.82716640 |
| 38 | MP0005023_abnormal_wound_healing | 0.76566026 |
| 39 | MP0001764_abnormal_homeostasis | 0.75393297 |
| 40 | MP0010155_abnormal_intestine_physiology | 0.74633535 |
| 41 | MP0009763_increased_sensitivity_to | 0.72998133 |
| 42 | MP0005197_abnormal_uvea_morphology | 0.70409922 |
| 43 | MP0000026_abnormal_inner_ear | 0.68435677 |
| 44 | MP0001963_abnormal_hearing_physiology | 0.67289024 |
| 45 | MP0000358_abnormal_cell_content/ | 0.66600488 |
| 46 | MP0000432_abnormal_head_morphology | 0.64769918 |
| 47 | MP0000477_abnormal_intestine_morphology | 0.63574905 |
| 48 | MP0005503_abnormal_tendon_morphology | 0.63236229 |
| 49 | MP0005275_abnormal_skin_tensile | 0.61931213 |
| 50 | MP0002405_respiratory_system_inflammati | 0.61309534 |
| 51 | MP0003011_delayed_dark_adaptation | 0.60927691 |
| 52 | MP0001175_abnormal_lung_morphology | 0.60062315 |
| 53 | MP0000604_amyloidosis | 0.56640862 |
| 54 | MP0003935_abnormal_craniofacial_develop | 0.55941221 |
| 55 | MP0002113_abnormal_skeleton_development | 0.55240485 |
| 56 | MP0000681_abnormal_thyroid_gland | 0.54694951 |
| 57 | MP0009672_abnormal_birth_weight | 0.54138523 |
| 58 | MP0002184_abnormal_innervation | 0.48861659 |
| 59 | MP0002210_abnormal_sex_determination | 0.48691356 |
| 60 | MP0003283_abnormal_digestive_organ | 0.47355532 |
| 61 | MP0003638_abnormal_response/metabolism_ | 0.44954491 |
| 62 | MP0000163_abnormal_cartilage_morphology | 0.44474422 |
| 63 | MP0003448_altered_tumor_morphology | 0.44108464 |
| 64 | MP0002168_other_aberrant_phenotype | 0.43599030 |
| 65 | MP0005253_abnormal_eye_physiology | 0.41596492 |
| 66 | MP0000377_abnormal_hair_follicle | 0.40908547 |
| 67 | MP0003936_abnormal_reproductive_system | 0.39424281 |
| 68 | MP0008438_abnormal_cutaneous_collagen | 0.39093641 |
| 69 | MP0000627_abnormal_mammary_gland | 0.37267785 |
| 70 | MP0005390_skeleton_phenotype | 0.34767061 |
| 71 | MP0002136_abnormal_kidney_physiology | 0.33160111 |
| 72 | MP0005391_vision/eye_phenotype | 0.31706705 |
| 73 | MP0010771_integument_phenotype | 0.31444606 |
| 74 | MP0002736_abnormal_nociception_after | 0.31371253 |
| 75 | MP0000343_altered_response_to | 0.29671796 |
| 76 | MP0005025_abnormal_response_to | 0.29387179 |
| 77 | MP0000350_abnormal_cell_proliferation | 0.27556630 |
| 78 | MP0003091_abnormal_cell_migration | 0.26416201 |
| 79 | MP0003195_calcinosis | 0.26054671 |
| 80 | MP0002697_abnormal_eye_size | 0.24756082 |
| 81 | MP0009931_abnormal_skin_appearance | 0.24106506 |
| 82 | MP0000049_abnormal_middle_ear | 0.23878120 |
| 83 | MP0001986_abnormal_taste_sensitivity | 0.22945620 |
| 84 | MP0008058_abnormal_DNA_repair | 0.21659531 |
| 85 | MP0004197_abnormal_fetal_growth/weight/ | 0.21342910 |
| 86 | MP0003315_abnormal_perineum_morphology | 0.20504479 |
| 87 | MP0002752_abnormal_somatic_nervous | 0.20177288 |
| 88 | MP0002116_abnormal_craniofacial_bone | 0.18276114 |
| 89 | MP0002822_catalepsy | 0.17621451 |
| 90 | MP0005332_abnormal_amino_acid | 0.17332161 |
| 91 | MP0004484_altered_response_of | 0.17201185 |
| 92 | MP0002735_abnormal_chemical_nociception | 0.16901905 |
| 93 | MP0002081_perinatal_lethality | 0.15850028 |
| 94 | MP0001968_abnormal_touch/_nociception | 0.15783834 |
| 95 | MP0002161_abnormal_fertility/fecundity | 0.14685973 |
| 96 | MP0003279_aneurysm | 0.14427644 |
| 97 | MP0001119_abnormal_female_reproductive | 0.14319179 |
| 98 | MP0002092_abnormal_eye_morphology | 0.14187627 |
| 99 | MP0001958_emphysema | 0.14090164 |
| 100 | MP0010386_abnormal_urinary_bladder | 0.13735276 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Duplicated collecting system (HP:0000081) | 9.22846452 |
| 2 | Long foot (HP:0001833) | 9.09835095 |
| 3 | Abnormality of the renal collecting system (HP:0004742) | 8.21859414 |
| 4 | Acute lymphatic leukemia (HP:0006721) | 7.27064702 |
| 5 | Large for gestational age (HP:0001520) | 7.17113273 |
| 6 | Adactyly (HP:0009776) | 6.58635312 |
| 7 | Progressive muscle weakness (HP:0003323) | 6.53822015 |
| 8 | Abnormality of fatty-acid metabolism (HP:0004359) | 6.10373977 |
| 9 | Hypoplastic pelvis (HP:0008839) | 6.00797557 |
| 10 | Autoamputation (HP:0001218) | 5.77417406 |
| 11 | Pulmonary artery stenosis (HP:0004415) | 5.72065538 |
| 12 | Dry hair (HP:0011359) | 5.55539112 |
| 13 | Ureteral stenosis (HP:0000071) | 5.40876818 |
| 14 | Menstrual irregularities (HP:0000858) | 5.21096815 |
| 15 | Steatorrhea (HP:0002570) | 5.08671784 |
| 16 | Ureteral obstruction (HP:0006000) | 5.06761834 |
| 17 | Ureteral duplication (HP:0000073) | 5.05783577 |
| 18 | Brushfield spots (HP:0001088) | 4.90572662 |
| 19 | Hypoplastic nipples (HP:0002557) | 4.89965847 |
| 20 | Abnormal auditory evoked potentials (HP:0006958) | 4.68220559 |
| 21 | Sudden death (HP:0001699) | 4.43186108 |
| 22 | Increased number of teeth (HP:0011069) | 4.40346123 |
| 23 | Reduced subcutaneous adipose tissue (HP:0003758) | 4.37786703 |
| 24 | Abnormal ventriculo-arterial connection (HP:0011563) | 4.32146159 |
| 25 | Transposition of the great arteries (HP:0001669) | 4.32146159 |
| 26 | Abnormal connection of the cardiac segments (HP:0011545) | 4.32146159 |
| 27 | Severe muscular hypotonia (HP:0006829) | 3.96441225 |
| 28 | Fat malabsorption (HP:0002630) | 3.92901074 |
| 29 | Decreased lacrimation (HP:0000633) | 3.88638439 |
| 30 | Anhidrosis (HP:0000970) | 3.83344111 |
| 31 | Palmoplantar hyperkeratosis (HP:0000972) | 3.62819213 |
| 32 | Broad-based gait (HP:0002136) | 3.59717762 |
| 33 | Abnormality of vision evoked potentials (HP:0000649) | 3.52101865 |
| 34 | Palmar hyperkeratosis (HP:0010765) | 3.40883315 |
| 35 | Generalized amyotrophy (HP:0003700) | 3.31349202 |
| 36 | Decreased muscle mass (HP:0003199) | 3.24634131 |
| 37 | Broad nasal tip (HP:0000455) | 3.24375251 |
| 38 | Wide intermamillary distance (HP:0006610) | 3.20585434 |
| 39 | Polyneuropathy (HP:0001271) | 3.17218833 |
| 40 | Large hands (HP:0001176) | 3.12659187 |
| 41 | Myoglobinuria (HP:0002913) | 3.03378268 |
| 42 | Polymicrogyria (HP:0002126) | 2.98514203 |
| 43 | Plantar hyperkeratosis (HP:0007556) | 2.89621872 |
| 44 | Rhabdomyolysis (HP:0003201) | 2.81077070 |
| 45 | Flat face (HP:0012368) | 2.70259871 |
| 46 | Steppage gait (HP:0003376) | 2.65312717 |
| 47 | Purpura (HP:0000979) | 2.61252368 |
| 48 | Hypoplastic iliac wings (HP:0002866) | 2.60405098 |
| 49 | Clubbing of toes (HP:0100760) | 2.59751242 |
| 50 | Epiphyseal stippling (HP:0010655) | 2.53731982 |
| 51 | Chorioretinal coloboma (HP:0000567) | 2.52610798 |
| 52 | Thickened calvaria (HP:0002684) | 2.48934449 |
| 53 | Foot dorsiflexor weakness (HP:0009027) | 2.42345342 |
| 54 | Widely spaced teeth (HP:0000687) | 2.39346399 |
| 55 | Overfolded helix (HP:0000396) | 2.32472581 |
| 56 | Basal ganglia calcification (HP:0002135) | 2.30829388 |
| 57 | Hammertoe (HP:0001765) | 2.26623570 |
| 58 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 2.22142472 |
| 59 | Abnormality of the foot musculature (HP:0001436) | 2.21660890 |
| 60 | Posterior embryotoxon (HP:0000627) | 2.17575177 |
| 61 | Absent toe (HP:0010760) | 2.17294715 |
| 62 | Abnormally folded helix (HP:0008544) | 2.11246227 |
| 63 | Abnormality of the line of Schwalbe (HP:0008048) | 2.09221905 |
| 64 | Anxiety (HP:0000739) | 2.00897097 |
| 65 | Prenatal maternal abnormality (HP:0002686) | 2.00345110 |
| 66 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 11.9066907 |
| 67 | Aplasia/Hypoplasia of the nipples (HP:0006709) | 1.99463421 |
| 68 | Female pseudohermaphroditism (HP:0010458) | 1.97933062 |
| 69 | Abnormality of the epiphyses of the hand (HP:0005924) | 1.94957091 |
| 70 | Thickened nuchal skin fold (HP:0000474) | 1.92580811 |
| 71 | Generalized muscle weakness (HP:0003324) | 1.89069341 |
| 72 | Decreased motor nerve conduction velocity (HP:0003431) | 1.87324724 |
| 73 | External ear malformation (HP:0008572) | 1.84315747 |
| 74 | Spastic tetraplegia (HP:0002510) | 1.84005563 |
| 75 | Stereotypic behavior (HP:0000733) | 1.82254358 |
| 76 | Abnormality involving the epiphyses of the upper limbs (HP:0003839) | 1.81966509 |
| 77 | Short philtrum (HP:0000322) | 1.81536849 |
| 78 | Abnormal epiphyseal ossification (HP:0010656) | 1.75497355 |
| 79 | Congenital onset (HP:0003577) | 1.74906683 |
| 80 | Arterial thrombosis (HP:0004420) | 1.74436705 |
| 81 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.74304485 |
| 82 | Primary adrenal insufficiency (HP:0008207) | 1.72162370 |
| 83 | Brachycephaly (HP:0000248) | 1.69882444 |
| 84 | Arthrogryposis multiplex congenita (HP:0002804) | 1.69630796 |
| 85 | Gangrene (HP:0100758) | 1.68346290 |
| 86 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 1.62194046 |
| 87 | Hypoplastic ilia (HP:0000946) | 1.54168570 |
| 88 | Scrotal hypoplasia (HP:0000046) | 1.51061755 |
| 89 | Underdeveloped supraorbital ridges (HP:0009891) | 1.49385464 |
| 90 | Venous insufficiency (HP:0005293) | 1.49160710 |
| 91 | Nail dystrophy (HP:0008404) | 1.46593653 |
| 92 | Depressed nasal ridge (HP:0000457) | 1.44893747 |
| 93 | Abnormality of primary teeth (HP:0006481) | 1.39569003 |
| 94 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.37859222 |
| 95 | Abnormality of the wing of the ilium (HP:0011867) | 1.35938508 |
| 96 | Webbed neck (HP:0000465) | 1.35757410 |
| 97 | Pulmonary embolism (HP:0002204) | 1.35271063 |
| 98 | Opacification of the corneal stroma (HP:0007759) | 1.28888655 |
| 99 | Freckling (HP:0001480) | 1.28788600 |
| 100 | Postnatal microcephaly (HP:0005484) | 1.28752619 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MKNK1 | 6.72780198 |
| 2 | TAOK2 | 5.59007442 |
| 3 | TAOK1 | 5.49435220 |
| 4 | MAP2K3 | 4.29118354 |
| 5 | MAP3K3 | 4.18982926 |
| 6 | MAP3K11 | 4.11329260 |
| 7 | JAK3 | 2.46619605 |
| 8 | MKNK2 | 11.4395323 |
| 9 | ABL2 | 1.88384146 |
| 10 | DYRK1A | 1.76006460 |
| 11 | MAP3K5 | 1.40559120 |
| 12 | MAP3K1 | 1.08684012 |
| 13 | SRPK1 | 0.90933468 |
| 14 | CHEK2 | 0.80039685 |
| 15 | MAP3K8 | 0.68726924 |
| 16 | PRKCQ | 0.48150761 |
| 17 | PIK3CG | 0.22120658 |
| 18 | ABL1 | 0.15997286 |
| 19 | INSRR | 0.15910997 |
| 20 | CSNK1A1 | 0.15685426 |
| 21 | IGF1R | 0.15014367 |
| 22 | DDR2 | 0.13940215 |
| 23 | TIE1 | 0.13460581 |
| 24 | OBSCN | 0.11079756 |
| 25 | PRKCD | 0.07542439 |
| 26 | ADRBK2 | 0.06247488 |
| 27 | MYLK | 0.05415837 |
| 28 | GRK7 | 0.04786971 |
| 29 | MUSK | 0.04639806 |
| 30 | GRK1 | 0.04414159 |
| 31 | MAP2K6 | 0.03747224 |
| 32 | TTN | 0.03713211 |
| 33 | PLK4 | 0.03290083 |
| 34 | MAP4K2 | 0.02791836 |
| 35 | CSNK2A2 | 0.02352011 |
| 36 | CSNK2A1 | 0.00546022 |
| 37 | ERBB4 | 0.00410681 |
| 38 | PRKCA | 0.00045657 |
| 39 | CSK | -0.1249719 |
| 40 | PLK2 | -0.1213796 |
| 41 | PRKCE | -0.1173320 |
| 42 | FES | -0.1171150 |
| 43 | IKBKE | -0.1167685 |
| 44 | PRKCG | -0.1167443 |
| 45 | ITK | -0.1151898 |
| 46 | CDK3 | -0.1141251 |
| 47 | PINK1 | -0.1138107 |
| 48 | NTRK2 | -0.1137338 |
| 49 | PRKACG | -0.1123779 |
| 50 | LYN | -0.1090958 |
| 51 | MAPK4 | -0.1078368 |
| 52 | TRIM28 | -0.1060413 |
| 53 | PIK3CA | -0.1058425 |
| 54 | EPHA2 | -0.1054953 |
| 55 | FRK | -0.1046655 |
| 56 | MAPK14 | -0.1030244 |
| 57 | PRKG1 | -0.1023954 |
| 58 | CAMK2A | -0.1020223 |
| 59 | CAMK2G | -0.1020190 |
| 60 | CDK2 | -0.1019099 |
| 61 | MAPK12 | -0.1004122 |
| 62 | BMX | -0.0986081 |
| 63 | PIM1 | -0.0974814 |
| 64 | BTK | -0.0962062 |
| 65 | PASK | -0.0927737 |
| 66 | WNK4 | -0.0904495 |
| 67 | NTRK1 | -0.0889023 |
| 68 | PKN1 | -0.0813346 |
| 69 | SYK | -0.0809147 |
| 70 | PIM2 | -0.0784651 |
| 71 | PHKG2 | -0.0760773 |
| 72 | PHKG1 | -0.0760773 |
| 73 | KIT | -0.0684374 |
| 74 | TAOK3 | -0.0682577 |
| 75 | GRK6 | -0.0638013 |
| 76 | PTK2B | -0.0629570 |
| 77 | KDR | -0.0576145 |
| 78 | NTRK3 | -0.0552391 |
| 79 | MAP2K4 | -0.0548122 |
| 80 | LMTK2 | -0.0532552 |
| 81 | CCNB1 | -0.0477270 |
| 82 | BLK | -0.0427961 |
| 83 | MST1R | -0.0419926 |
| 84 | TGFBR2 | -0.0399389 |
| 85 | WEE1 | -0.0388257 |
| 86 | GRK5 | -0.0376058 |
| 87 | TEC | -0.0374830 |
| 88 | AKT3 | -0.0357115 |
| 89 | SIK2 | -0.0333774 |
| 90 | PRKACA | -0.0310144 |
| 91 | ADRBK1 | -0.0274725 |
| 92 | TXK | -0.0210039 |
| 93 | AURKA | -0.0209311 |
| 94 | FLT3 | -0.0191362 |
| 95 | PRKCB | -0.0155711 |
| 96 | SRC | -0.0137260 |
| 97 | WNK3 | -0.0106549 |
| 98 | MAPK15 | -0.0075169 |
| 99 | CSNK1E | -0.0048643 |
| 100 | MATK | -0.0018932 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 8.77778210 |
| 2 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 7.26062153 |
| 3 | Taste transduction_Homo sapiens_hsa04742 | 3.19718622 |
| 4 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 3.15833102 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.92751421 |
| 6 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.71259988 |
| 7 | RNA polymerase_Homo sapiens_hsa03020 | 2.68854152 |
| 8 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.64054317 |
| 9 | Lysine degradation_Homo sapiens_hsa00310 | 2.58339478 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.39676992 |
| 11 | Amoebiasis_Homo sapiens_hsa05146 | 2.06062687 |
| 12 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.79022642 |
| 13 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.76201143 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.65836725 |
| 15 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.64477449 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.41138060 |
| 17 | Proteasome_Homo sapiens_hsa03050 | 1.27319793 |
| 18 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.18172859 |
| 19 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.16756793 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.08575220 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.08164212 |
| 22 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.04861278 |
| 23 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.01065491 |
| 24 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.87154122 |
| 25 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.76533591 |
| 26 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.74933663 |
| 27 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.71988012 |
| 28 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.70908438 |
| 29 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.67159723 |
| 30 | Peroxisome_Homo sapiens_hsa04146 | 0.66306354 |
| 31 | Olfactory transduction_Homo sapiens_hsa04740 | 0.64536580 |
| 32 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.64000112 |
| 33 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.62977850 |
| 34 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.61394937 |
| 35 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.59968456 |
| 36 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59360466 |
| 37 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.59095232 |
| 38 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.59066225 |
| 39 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58225601 |
| 40 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.57300785 |
| 41 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.55735205 |
| 42 | Malaria_Homo sapiens_hsa05144 | 0.54101124 |
| 43 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.54071805 |
| 44 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.53380790 |
| 45 | Salmonella infection_Homo sapiens_hsa05132 | 0.52973891 |
| 46 | Nicotine addiction_Homo sapiens_hsa05033 | 0.52638318 |
| 47 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.48898165 |
| 48 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.47300802 |
| 49 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.46185782 |
| 50 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.44622295 |
| 51 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.44515056 |
| 52 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41736325 |
| 53 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.41711238 |
| 54 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.40891111 |
| 55 | Retinol metabolism_Homo sapiens_hsa00830 | 0.40802346 |
| 56 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.36985186 |
| 57 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.34103307 |
| 58 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.33805320 |
| 59 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.33406466 |
| 60 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.32225045 |
| 61 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.30907910 |
| 62 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.30151158 |
| 63 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.29522945 |
| 64 | Asthma_Homo sapiens_hsa05310 | 0.28432667 |
| 65 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.25902993 |
| 66 | Phagosome_Homo sapiens_hsa04145 | 0.25618447 |
| 67 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.24723937 |
| 68 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.23677152 |
| 69 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.23441042 |
| 70 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.22936079 |
| 71 | Phototransduction_Homo sapiens_hsa04744 | 0.21755944 |
| 72 | Allograft rejection_Homo sapiens_hsa05330 | 0.21591111 |
| 73 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.20808053 |
| 74 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.20544362 |
| 75 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.20275186 |
| 76 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.19641019 |
| 77 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.19537335 |
| 78 | RNA transport_Homo sapiens_hsa03013 | 0.19426948 |
| 79 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.19029328 |
| 80 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.18778288 |
| 81 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.18632320 |
| 82 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.18317945 |
| 83 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.18072781 |
| 84 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.17702677 |
| 85 | Purine metabolism_Homo sapiens_hsa00230 | 0.17639715 |
| 86 | Influenza A_Homo sapiens_hsa05164 | 0.16427717 |
| 87 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.15987733 |
| 88 | Tuberculosis_Homo sapiens_hsa05152 | 0.15205210 |
| 89 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.14748389 |
| 90 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.14646280 |
| 91 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.14181603 |
| 92 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.13865688 |
| 93 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.13017907 |
| 94 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.12681519 |
| 95 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.11186415 |
| 96 | Bile secretion_Homo sapiens_hsa04976 | 0.10776091 |
| 97 | Salivary secretion_Homo sapiens_hsa04970 | 0.09879102 |
| 98 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.09357063 |
| 99 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.08156448 |
| 100 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.05510045 |

